Logo image of APO

APOLLO GLOBAL MANAGEMENT INC (APO) Stock Fundamental Analysis

NYSE:APO - New York Stock Exchange, Inc. - US03769M1062 - Common Stock - Currency: USD

141.63  -0.24 (-0.17%)

Premarket: 142.02 +0.39 (+0.28%)

Fundamental Rating

4

APO gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 100 industry peers in the Financial Services industry. While APO is still in line with the averages on profitability rating, there are concerns on its financial health. APO has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

APO had positive earnings in the past year.
APO had a positive operating cash flow in the past year.
Of the past 5 years APO 4 years were profitable.
Of the past 5 years APO 4 years had a positive operating cash flow.
APO Yearly Net Income VS EBIT VS OCF VS FCFAPO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B 4B -4B 6B

1.2 Ratios

With a Return On Assets value of 0.85%, APO is not doing good in the industry: 60.00% of the companies in the same industry are doing better.
APO has a better Return On Equity (18.75%) than 82.00% of its industry peers.
APO has a Return On Invested Capital (1.56%) which is in line with its industry peers.
Industry RankSector Rank
ROA 0.85%
ROE 18.75%
ROIC 1.56%
ROA(3y)0.64%
ROA(5y)1.66%
ROE(3y)9.76%
ROE(5y)17.05%
ROIC(3y)N/A
ROIC(5y)N/A
APO Yearly ROA, ROE, ROICAPO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

1.3 Margins

With a decent Profit Margin value of 15.23%, APO is doing good in the industry, outperforming 64.00% of the companies in the same industry.
APO's Profit Margin has declined in the last couple of years.
APO has a better Operating Margin (31.69%) than 74.00% of its industry peers.
In the last couple of years the Operating Margin of APO has declined.
Industry RankSector Rank
OM 31.69%
PM (TTM) 15.23%
GM N/A
OM growth 3Y-2.59%
OM growth 5Y-7.21%
PM growth 3Y-15.29%
PM growth 5Y-7.97%
GM growth 3YN/A
GM growth 5YN/A
APO Yearly Profit, Operating, Gross MarginsAPO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so APO is destroying value.
The number of shares outstanding for APO has been reduced compared to 1 year ago.
The number of shares outstanding for APO has been increased compared to 5 years ago.
APO has about the same debt/assets ratio as last year.
APO Yearly Shares OutstandingAPO Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M
APO Yearly Total Debt VS Total AssetsAPO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100B 200B 300B

2.2 Solvency

Based on the Altman-Z score of 0.24, we must say that APO is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of APO (0.24) is comparable to the rest of the industry.
APO has a debt to FCF ratio of 3.25. This is a good value and a sign of high solvency as APO would need 3.25 years to pay back of all of its debts.
APO's Debt to FCF ratio of 3.25 is fine compared to the rest of the industry. APO outperforms 74.00% of its industry peers.
APO has a Debt/Equity ratio of 0.76. This is a neutral value indicating APO is somewhat dependend on debt financing.
APO has a Debt to Equity ratio (0.76) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.76
Debt/FCF 3.25
Altman-Z 0.24
ROIC/WACC0.18
WACC8.49%
APO Yearly LT Debt VS Equity VS FCFAPO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B 15B

2.3 Liquidity

APO has a Current Ratio of 0.07. This is a bad value and indicates that APO is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.07, APO is doing worse than 81.00% of the companies in the same industry.
A Quick Ratio of 0.07 indicates that APO may have some problems paying its short term obligations.
APO has a Quick ratio of 0.07. This is amonst the worse of the industry: APO underperforms 81.00% of its industry peers.
Industry RankSector Rank
Current Ratio 0.07
Quick Ratio 0.07
APO Yearly Current Assets VS Current LiabilitesAPO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

5

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 6.96% over the past year.
Measured over the past years, APO shows a very strong growth in Earnings Per Share. The EPS has been growing by 22.44% on average per year.
Looking at the last year, APO shows a very negative growth in Revenue. The Revenue has decreased by -31.66% in the last year.
Measured over the past years, APO shows a very strong growth in Revenue. The Revenue has been growing by 52.06% on average per year.
EPS 1Y (TTM)6.96%
EPS 3Y17.67%
EPS 5Y22.44%
EPS Q2Q%5.81%
Revenue 1Y (TTM)-31.66%
Revenue growth 3Y58.1%
Revenue growth 5Y52.06%
Sales Q2Q%-21.19%

3.2 Future

APO is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 15.04% yearly.
The Revenue is expected to decrease by -12.07% on average over the next years. This is quite bad
EPS Next Y5.54%
EPS Next 2Y12.81%
EPS Next 3Y15.04%
EPS Next 5YN/A
Revenue Next Year16.43%
Revenue Next 2Y17.49%
Revenue Next 3Y16.65%
Revenue Next 5Y-12.07%

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
APO Yearly Revenue VS EstimatesAPO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 10B 20B 30B
APO Yearly EPS VS EstimatesAPO Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 4 6 8 10

4

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 18.81, the valuation of APO can be described as rather expensive.
The rest of the industry has a similar Price/Earnings ratio as APO.
The average S&P500 Price/Earnings ratio is at 27.21. APO is valued slightly cheaper when compared to this.
With a Price/Forward Earnings ratio of 14.98, APO is valued correctly.
APO's Price/Forward Earnings is on the same level as the industry average.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.70, APO is valued a bit cheaper.
Industry RankSector Rank
PE 18.81
Fwd PE 14.98
APO Price Earnings VS Forward Price EarningsAPO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, APO is valued a bit cheaper than 69.00% of the companies in the same industry.
62.00% of the companies in the same industry are more expensive than APO, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 19.29
EV/EBITDA 9.96
APO Per share dataAPO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
A more expensive valuation may be justified as APO's earnings are expected to grow with 15.04% in the coming years.
PEG (NY)3.4
PEG (5Y)0.84
EPS Next 2Y12.81%
EPS Next 3Y15.04%

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.46%, APO has a reasonable but not impressive dividend return.
APO's Dividend Yield is a higher than the industry average which is at 4.97.
Compared to the average S&P500 Dividend Yield of 2.42, APO is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.46%

5.2 History

The dividend of APO decreases each year by -1.16%.
APO has paid a dividend for at least 10 years, which is a reliable track record.
APO has decreased its dividend in the last 3 years.
Dividend Growth(5Y)-1.16%
Div Incr Years2
Div Non Decr Years2
APO Yearly Dividends per shareAPO Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2

5.3 Sustainability

APO pays out 35.84% of its income as dividend. This is a sustainable payout ratio.
DP35.84%
EPS Next 2Y12.81%
EPS Next 3Y15.04%
APO Yearly Income VS Free CF VS DividendAPO Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B 4B 6B
APO Dividend Payout.APO Dividend Payout, showing the Payout Ratio.APO Dividend Payout.PayoutRetained Earnings

APOLLO GLOBAL MANAGEMENT INC

NYSE:APO (7/1/2025, 9:27:40 PM)

Premarket: 142.02 +0.39 (+0.28%)

141.63

-0.24 (-0.17%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)05-02 2025-05-02/bmo
Earnings (Next)07-30 2025-07-30/bmo
Inst Owners65.51%
Inst Owner Change4.62%
Ins Owners3.12%
Ins Owner Change-0.23%
Market Cap80.94B
Analysts80
Price Target160.91 (13.61%)
Short Float %6.77%
Short Ratio8.57
Dividend
Industry RankSector Rank
Dividend Yield 1.46%
Yearly Dividend2.1
Dividend Growth(5Y)-1.16%
DP35.84%
Div Incr Years2
Div Non Decr Years2
Ex-Date05-16 2025-05-16 (0.51)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)6.44%
Min EPS beat(2)-3.45%
Max EPS beat(2)16.32%
EPS beat(4)2
Avg EPS beat(4)2.87%
Min EPS beat(4)-7.59%
Max EPS beat(4)16.32%
EPS beat(8)4
Avg EPS beat(8)1.84%
EPS beat(12)5
Avg EPS beat(12)0.19%
EPS beat(16)8
Avg EPS beat(16)8.44%
Revenue beat(2)2
Avg Revenue beat(2)21.08%
Min Revenue beat(2)19.9%
Max Revenue beat(2)22.26%
Revenue beat(4)4
Avg Revenue beat(4)45.54%
Min Revenue beat(4)19.9%
Max Revenue beat(4)86.31%
Revenue beat(8)7
Avg Revenue beat(8)93.22%
Revenue beat(12)11
Avg Revenue beat(12)107.55%
Revenue beat(16)14
Avg Revenue beat(16)87.65%
PT rev (1m)2.1%
PT rev (3m)-14.27%
EPS NQ rev (1m)0.01%
EPS NQ rev (3m)-7.59%
EPS NY rev (1m)0.02%
EPS NY rev (3m)-7.06%
Revenue NQ rev (1m)-1.02%
Revenue NQ rev (3m)-1.4%
Revenue NY rev (1m)0.43%
Revenue NY rev (3m)-0.96%
Valuation
Industry RankSector Rank
PE 18.81
Fwd PE 14.98
P/S 3.66
P/FCF 19.29
P/OCF 19.29
P/B 4.5
P/tB 5.93
EV/EBITDA 9.96
EPS(TTM)7.53
EY5.32%
EPS(NY)9.46
Fwd EY6.68%
FCF(TTM)7.34
FCFY5.18%
OCF(TTM)7.34
OCFY5.18%
SpS38.73
BVpS31.45
TBVpS23.88
PEG (NY)3.4
PEG (5Y)0.84
Profitability
Industry RankSector Rank
ROA 0.85%
ROE 18.75%
ROCE 1.82%
ROIC 1.56%
ROICexc 1.61%
ROICexgc 1.78%
OM 31.69%
PM (TTM) 15.23%
GM N/A
FCFM 18.95%
ROA(3y)0.64%
ROA(5y)1.66%
ROE(3y)9.76%
ROE(5y)17.05%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y-33.79%
ROICexcg growth 5Y-38.36%
ROICexc growth 3Y-35.62%
ROICexc growth 5Y-38.99%
OM growth 3Y-2.59%
OM growth 5Y-7.21%
PM growth 3Y-15.29%
PM growth 5Y-7.97%
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.06
Health
Industry RankSector Rank
Debt/Equity 0.76
Debt/FCF 3.25
Debt/EBITDA 1.67
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 7.31
Cash Conversion 51.41%
Profit Quality 124.44%
Current Ratio 0.07
Quick Ratio 0.07
Altman-Z 0.24
F-Score6
WACC8.49%
ROIC/WACC0.18
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)6.96%
EPS 3Y17.67%
EPS 5Y22.44%
EPS Q2Q%5.81%
EPS Next Y5.54%
EPS Next 2Y12.81%
EPS Next 3Y15.04%
EPS Next 5YN/A
Revenue 1Y (TTM)-31.66%
Revenue growth 3Y58.1%
Revenue growth 5Y52.06%
Sales Q2Q%-21.19%
Revenue Next Year16.43%
Revenue Next 2Y17.49%
Revenue Next 3Y16.65%
Revenue Next 5Y-12.07%
EBIT growth 1Y17.58%
EBIT growth 3Y54.01%
EBIT growth 5Y41.09%
EBIT Next Year10.94%
EBIT Next 3Y13.27%
EBIT Next 5YN/A
FCF growth 1Y-52.61%
FCF growth 3Y48.2%
FCF growth 5Y25.54%
OCF growth 1Y-52.61%
OCF growth 3Y45.14%
OCF growth 5Y24.61%